$194 Million is the total value of Birchview Capital, LP's 0 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 31.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Sell | CELGENE CORP | $110,976,000 | +10.3% | 761,051 | -1.8% | 57.32% | +7.7% |
| AXDX | ACCELERATE DIAGNOSTICS INC | $49,026,000 | -17.9% | 2,183,795 | 0.0% | 25.32% | -19.8% | |
| VRML | Buy | VERMILLION INC | $4,433,000 | +5.5% | 2,462,933 | +7.9% | 2.29% | +3.1% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $3,211,000 | +177.0% | 52,400 | +107.9% | 1.66% | +170.6% |
| EQT | EQT CORP | $2,760,000 | +11.4% | 42,300 | 0.0% | 1.43% | +8.8% | |
| CORT | CORCEPT THERAPEUTICS INC | $1,834,000 | +63.6% | 95,000 | 0.0% | 0.95% | +59.7% | |
| QDEL | QUIDEL CORP | $1,709,000 | +61.5% | 38,975 | 0.0% | 0.88% | +57.7% | |
| ECA | ENCANA CORP | $1,558,000 | +33.8% | 132,300 | 0.0% | 0.80% | +30.7% | |
| AAAP | Buy | ADVANCED ACCELERATOR APPLICATIONS SA | $1,488,000 | +90.5% | 22,000 | +10.0% | 0.77% | +86.2% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $1,299,000 | +14.8% | 77,303 | +14.9% | 0.67% | +12.0% |
| CFRX | Buy | CONTRAFECT CORP | $1,260,000 | +19.9% | 1,135,082 | +56.5% | 0.65% | +17.1% |
| VNDA | VANDA PHARMACEUTICALS INC | $1,217,000 | +9.8% | 68,000 | 0.0% | 0.63% | +7.3% | |
| VCYT | Buy | VERACYTE INC | $1,042,000 | +26.6% | 118,767 | +20.2% | 0.54% | +23.7% |
| SIEN | SIENTRA INC | $975,000 | +58.5% | 63,300 | 0.0% | 0.50% | +55.1% | |
| XLRN | Buy | ACCELERON PHARMA INC | $933,000 | +104.6% | 25,000 | +66.7% | 0.48% | +100.0% |
| SITOQ | Sell | SITO MOBILE LTD | $857,000 | +65.1% | 120,000 | -14.3% | 0.44% | +61.1% |
| T107PS | WRIGHT MEDICAL GROUP NV | $776,000 | -5.9% | 30,000 | 0.0% | 0.40% | -8.0% | |
| BIOL | BIOLASE INC | $775,000 | -37.9% | 1,285,903 | 0.0% | 0.40% | -39.4% | |
| YTEN | YIELD10 BIOSCIENCE INC | $722,000 | -31.2% | 226,317 | 0.0% | 0.37% | -32.8% | |
| MASI | MASIMO CORP | $692,000 | -5.1% | 8,000 | 0.0% | 0.36% | -7.5% | |
| TSRO | TESARO INC | $671,000 | -7.7% | 5,200 | 0.0% | 0.35% | -9.9% | |
| MRK | MERCK & CO INC | $640,000 | -0.2% | 10,000 | 0.0% | 0.33% | -2.4% | |
| VYGR | New | VOYAGER THERAPEUTICS INC | $494,000 | – | 24,000 | +100.0% | 0.26% | – |
| PXD | PIONEER NATURAL RESOURCES CO | $443,000 | -7.5% | 3,000 | 0.0% | 0.23% | -9.5% | |
| CELGZ | CELGENE CORPright 12/31/2030 | $443,000 | +23.1% | 291,877 | 0.0% | 0.23% | +20.5% | |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $412,000 | -37.1% | 5,000 | -28.6% | 0.21% | -38.6% |
| CMTA | New | CLEMENTIA PHARMACEUTICALS INC | $372,000 | – | 22,000 | +100.0% | 0.19% | – |
| BIIB | BIOGEN INC | $313,000 | +15.5% | 1,000 | 0.0% | 0.16% | +13.3% | |
| QTNT | Sell | QUOTIENT LTD | $294,000 | -49.9% | 59,700 | -25.1% | 0.15% | -51.1% |
| XNCR | XENCOR INC | $282,000 | +8.5% | 12,300 | 0.0% | 0.15% | +5.8% | |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $259,000 | +311.1% | 45,000 | +125.0% | 0.13% | +306.1% |
| ICPT | New | INTERCEPT PHARMACEUTICALS INC | $250,000 | – | 4,300 | +100.0% | 0.13% | – |
| PRTA | New | PROTHENA CORP PLC | $235,000 | – | 3,632 | +100.0% | 0.12% | – |
| GNMX | AEVI GENOMIC MEDICINE INC | $161,000 | -5.3% | 128,000 | 0.0% | 0.08% | -7.8% | |
| IRONWOOD PHARMACEUTICALS INC | $158,000 | -16.4% | 10,000 | 0.0% | 0.08% | -18.0% | ||
| FOLD | New | AMICUS THERAPEUTICS INC | $151,000 | – | 10,000 | +100.0% | 0.08% | – |
| CYTK | New | CYTOKINETICS INC | $145,000 | – | 10,000 | +100.0% | 0.08% | – |
| WKHS | WORKHORSE GROUP INC | $138,000 | -25.4% | 50,000 | 0.0% | 0.07% | -27.6% | |
| OMED | ONCOMED PHARMACEUTICALS INC | $130,000 | +35.4% | 28,689 | 0.0% | 0.07% | +31.4% | |
| GNCA | GENOCEA BIOSCIENCES INC | $57,000 | -72.1% | 39,000 | 0.0% | 0.03% | -73.1% | |
| MACK | Exit | MERRIMACK PHARMACEUTICALS INC | $0 | – | -44,000 | -100.0% | -0.03% | – |
| PACB | Exit | PACIFIC BIOSCIENCES OF CALIFORNIA INC | $0 | – | -27,000 | -100.0% | -0.05% | – |
| ROKA | Exit | ROKA BIOSCIENCE INC | $0 | – | -46,731 | -100.0% | -0.06% | – |
| OPK | Exit | OPKO HEALTH INC | $0 | – | -24,158 | -100.0% | -0.08% | – |
| ADXS | Exit | ADVAXIS INC | $0 | – | -35,600 | -100.0% | -0.12% | – |
| PRTK | Exit | PARATEK PHARMACEUTICALS INC | $0 | – | -30,150 | -100.0% | -0.38% | – |
| NXTM | Exit | NXSTAGE MEDICAL INC | $0 | – | -34,200 | -100.0% | -0.45% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-02
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
| QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
| MASIMO CORP | 36 | Q3 2023 | 2.2% |
| PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
| XENCOR INC | 35 | Q3 2023 | 0.4% |
| NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
| CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
| BIOGEN INC | 31 | Q2 2022 | 3.1% |
| CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
| YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
| YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
| HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
| METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3/A | 2024-02-20 |
| 4/A | 2024-02-20 |
| SC 13G/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-04-07 |
| 4 | 2023-03-27 |
| 3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.